These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 29658349)
1. Biodegradable hybrid-structured nanofibrous membrane supported chemoprotective gene therapy enhances chemotherapy tolerance and efficacy in malignant glioma rats. Liu SJ; Yang TC; Yang ST; Chen YC; Tseng YY Artif Cells Nanomed Biotechnol; 2018; 46(sup2):515-526. PubMed ID: 29658349 [TBL] [Abstract][Full Text] [Related]
2. Novel multi-drugs incorporating hybrid-structured nanofibers enhance alkylating agent activity in malignant gliomas. Liu SJ; Yang ST; Chen SM; Huang YC; Lee WH; Ho J; Chen YC; Tseng YY Ther Adv Med Oncol; 2019; 11():1758835919875555. PubMed ID: 31632467 [TBL] [Abstract][Full Text] [Related]
3. Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes. Tseng YY; Su CH; Yang ST; Huang YC; Lee WH; Wang YC; Liu SC; Liu SJ Oncotarget; 2016 Sep; 7(37):59902-59916. PubMed ID: 27494894 [TBL] [Abstract][Full Text] [Related]
4. Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes. Tseng YY; Yang TC; Wang YC; Lee WH; Chang TM; Kau YC; Liu SJ Int J Nanomedicine; 2017; 12():1265-1276. PubMed ID: 28243088 [TBL] [Abstract][Full Text] [Related]
5. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma. Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789 [TBL] [Abstract][Full Text] [Related]
6. Sustainable release of carmustine from biodegradable poly[((D,L))-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity: in vitro and in vivo studies. Tseng YY; Liao JY; Chen WA; Kao YC; Liu SJ Expert Opin Drug Deliv; 2013 Jul; 10(7):879-88. PubMed ID: 23289446 [TBL] [Abstract][Full Text] [Related]
7. Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. Weingart J; Grossman SA; Carson KA; Fisher JD; Delaney SM; Rosenblum ML; Olivi A; Judy K; Tatter SB; Dolan ME J Clin Oncol; 2007 Feb; 25(4):399-404. PubMed ID: 17264335 [TBL] [Abstract][Full Text] [Related]
8. Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide. Kokkinakis DM; Bocangel DB; Schold SC; Moschel RC; Pegg AE Clin Cancer Res; 2001 Feb; 7(2):421-8. PubMed ID: 11234899 [TBL] [Abstract][Full Text] [Related]
9. Cationic core-shell nanoparticles with carmustine contained within O⁶-benzylguanine shell for glioma therapy. Qian L; Zheng J; Wang K; Tang Y; Zhang X; Zhang H; Huang F; Pei Y; Jiang Y Biomaterials; 2013 Nov; 34(35):8968-78. PubMed ID: 23953782 [TBL] [Abstract][Full Text] [Related]
10. Concurrent delivery of carmustine, irinotecan, and cisplatin to the cerebral cavity using biodegradable nanofibers: In vitro and in vivo studies. Tseng YY; Wang YC; Su CH; Yang TC; Chang TM; Kau YC; Liu SJ Colloids Surf B Biointerfaces; 2015 Oct; 134():254-61. PubMed ID: 26209775 [TBL] [Abstract][Full Text] [Related]
11. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres. Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693 [TBL] [Abstract][Full Text] [Related]
12. Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes. Tseng YY; Huang YC; Yang TC; Yang ST; Liu SC; Chang TM; Kau YC; Liu SJ Sci Rep; 2016 Jul; 6():30630. PubMed ID: 27471070 [TBL] [Abstract][Full Text] [Related]
13. iRGD-mediated core-shell nanoparticles loading carmustine and O Liu C; Yao S; Li X; Wang F; Jiang Y J Drug Target; 2017 Mar; 25(3):235-246. PubMed ID: 27646474 [TBL] [Abstract][Full Text] [Related]
14. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model. Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer. Liu L; Schwartz S; Davis BM; Gerson SL Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916 [TBL] [Abstract][Full Text] [Related]
16. O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU. Wedge SR; Newlands ES Br J Cancer; 1996 May; 73(9):1049-52. PubMed ID: 8624262 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma. Quinn JA; Pluda J; Dolan ME; Delaney S; Kaplan R; Rich JN; Friedman AH; Reardon DA; Sampson JH; Colvin OM; Haglund MM; Pegg AE; Moschel RC; McLendon RE; Provenzale JM; Gururangan S; Tourt-Uhlig S; Herndon JE; Bigner DD; Friedman HS J Clin Oncol; 2002 May; 20(9):2277-83. PubMed ID: 11980998 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. Kanzawa T; Bedwell J; Kondo Y; Kondo S; Germano IM J Neurosurg; 2003 Dec; 99(6):1047-52. PubMed ID: 14705733 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro. Wedge SR; Porteus JK; May BL; Newlands ES Br J Cancer; 1996 Feb; 73(4):482-90. PubMed ID: 8595163 [TBL] [Abstract][Full Text] [Related]
20. Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer. Schilsky RL; Dolan ME; Bertucci D; Ewesuedo RB; Vogelzang NJ; Mani S; Wilson LR; Ratain MJ Clin Cancer Res; 2000 Aug; 6(8):3025-31. PubMed ID: 10955780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]